Related references
Note: Only part of the references are listed.The interaction between Siglec-15 and tumor-associated sialyl-Tn antigen enhances TGF-β secretion from monocytes/macrophages through the DAP12-Syk pathway
Rina Takamiya et al.
GLYCOBIOLOGY (2013)
Differential expression profiles of glycosphingolipids in human breast cancer stem cells vs. cancer non-stem cells
Yuh-Jin Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Siglecs as sensors of self in innate and adaptive immune responses
James C. Paulson et al.
GLYCOBIOLOGY OF THE IMMUNE RESPONSE (2012)
Investigating Cell Surface Galectin-Mediated Cross-Linking on Glycoengineered Cells
Brian Belardi et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
A sulfated carbohydrate epitope inhibits axon regeneration after injury
Joshua M. Brown et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Targeting natural killer cells and natural killer T cells in cancer
Eric Vivier et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer
Kristiina Aalto et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
Emilie Mamessier et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Protein Glycoengineering Enabled by the Versatile Synthesis of Aminooxy Glycans and the Genetically Encoded Aldehyde Tag
Jason E. Hudak et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)
Natural Killer Cells and the Immune Response in Solid Organ Transplantation
W. van der Touw et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Chemical Approaches to Glycobiology
Laura L. Kiessling et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 79 (2010)
Antibody-Dependent Natural Killer Cell-Mediated Cytotoxicity Engendered by a Kinase-Inactive Human HER2 Adenovirus-Based Vaccination Mediates Resistance to Breast Tumors
Chiara Triulzi et al.
CANCER RESEARCH (2010)
Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells
Yoshihide Kawasaki et al.
GLYCOBIOLOGY (2010)
Sialylation of 3-Methylcholanthrene-Induced Fibrosarcoma Determines Antitumor Immune Responses during Immunoediting
Merav Cohen et al.
JOURNAL OF IMMUNOLOGY (2010)
Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
Jennifer A. Belisle et al.
MOLECULAR CANCER (2010)
Sialylated multivalent antigens engage CD22 in trans and inhibit B cell activation
Adam H. Courtney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Xenotransplantation: Role of natural immunity
Shengqiao Li et al.
TRANSPLANT IMMUNOLOGY (2009)
Immunoreceptor tyrosine-based inhibition motifs:: a quest in the past and future
Marc Daeron et al.
IMMUNOLOGICAL REVIEWS (2008)
Noncovalent cell surface engineering: Incorporation of bioactive synthetic glycopolymers into cellular membranes
David Rabuka et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Natural killer cell-directed therapies: moving from unexpected results to successful strategies
Magali Terme et al.
NATURE IMMUNOLOGY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Mammalian glycosylation in immunity
Jamey D. Marth et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Hierarchical assembly of model cell surfaces: Synthesis of mucin mimetic polymers and their display on supported bilayers
David Rabuka et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2007)
Siglecs and their roles in the immune system
Paul R. Crocker et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Siglec-7 undergoes a major conformational change when complexed with the α(2,8)-disialylganglioside GT1b
Helen Attrill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Probing the cis interactions of the inhibitory receptor Siglec-7 with α2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of α2,8-sialyltransferase gene expression
Tony Avril et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
High-affinity ligand probes of CD22 overcome the threshold set by cis ligands for binding, endocytosis, and killing of B cells
Brian E. Collins et al.
JOURNAL OF IMMUNOLOGY (2006)
Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2
R Godal et al.
BLOOD (2006)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)
Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D
P Forte et al.
JOURNAL OF IMMUNOLOGY (2005)
The sweet and sour of cancer: Glycans as novel therapeutic targets
MM Fuster et al.
NATURE REVIEWS CANCER (2005)
Epratuzumab, a humanized anti-CD22 antibody, in aggressive non-Hodgkin's lymphoma: Phase I/II clinical trial results
JP Leonard et al.
CLINICAL CANCER RESEARCH (2004)
The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by siglecs-7 and-9, CD33-related Siglecs expressed on human monocytes and NK cells
T Avril et al.
JOURNAL OF IMMUNOLOGY (2004)
Cell surface biology mediated by low affinity multivalent protein-glycan interactions
BE Collins et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2004)
Rituximab-dependent cytotoxicity by natural killer cells:: Influence of FCGR3A polymorphism on the concentration-effect relationship
S Dall'Ozzo et al.
CANCER RESEARCH (2004)
Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9
Y Ikehara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Biologic and therapeutic role of HER2 in cancer
S Ménard et al.
ONCOGENE (2003)
Sialoside specificity of the siglec family assessed using novel multivalent probes - Identification of potent inhibitors of myelin-associated glycoprotein
O Blixt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms
G Nicoll et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies
WJ Murphy et al.
IMMUNOLOGICAL REVIEWS (2001)
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92
G Maki et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2001)
Share Paper
